Protalix BioTherapeutics
PLX
#8587
Rank
S$0.16 B
Marketcap
$2.21
Share price
-2.96%
Change (1 day)
18.72%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: S$0.16 Billion

As of November 2024 Protalix BioTherapeutics has a market cap of S$0.16 Billion. This makes Protalix BioTherapeutics the world's 8587th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 1997 to 2024

End of year Market Cap

Year Marketcap Change
2024S$0.16 B-5.23%
2023S$0.17 B84.3%
2022S$93.05 M81.66%
2021S$51.22 M-68%
2020S$0.16 B143.99%
2019S$65.61 M4.08%
2018S$63.04 M-48.98%
2017S$0.12 B55.01%
2016S$79.71 M-44.64%
2015S$0.14 B-36.73%
2014S$0.22 B-50.61%
2013S$0.46 B-22.35%
2012S$0.59 B8.54%
2011S$0.54 B-47.4%
2010S$1.03 B38.32%
2009S$0.75 B276.03%
2008S$0.19 B-46.11%
2007S$0.37 B-76.57%
2006S$1.58 B3734.43%
2005S$41.26 M4237.53%
2004S$0.95 M-51.99%
2003S$1.98 M256.06%
2002S$0.55 M-55.17%
2001S$1.24 M-2.63%
2000S$1.27 M-4.07%
1999S$1.32 M-85.92%
1998S$9.43 M-75.61%
1997S$38.68 M

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Protalix BioTherapeutics was reported to be:

S$0.16 Billion
by Nasdaq info icon info icon
S$0.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$3.81 B 2,249.58%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.03 B 10,379.44%๐Ÿ‡บ๐Ÿ‡ธ USA
S$190.53 B 117,127.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$26.00 B 15,898.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel